A detailed history of Engineers Gate Manager LP transactions in Humacyte, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 14,557 shares of HUMA stock, worth $51,531. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,557
Holding current value
$51,531
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$3.46 - $5.81 $50,367 - $84,576
14,557 New
14,557 $73,000
Q2 2024

Aug 14, 2024

BUY
$2.87 - $9.1 $288,607 - $915,096
100,560 New
100,560 $482,000

Others Institutions Holding HUMA

About Humacyte, Inc.


  • Ticker HUMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,007,000
  • Market Cap $365M
  • Description
  • Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...
More about HUMA
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.